Premera Blue Cross:企業の戦略的SWOT分析

◆英語タイトル:Premera Blue Cross - Strategic SWOT Analysis Review
◆商品コード:DATA904C12811
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Premera Blue Cross – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

Premera Blue Cross (PBC) provides health and wellness solutions. It specializes in offering comprehensive health benefits and tailored services. PBC provides health, vision, life, dental, disability, workforce wellness, stop-loss, and long-term care insurance, and other related products and services. The company provides services through a wide network of health care professionals and hospitals in Washington, Oregon and Alaska. It offers individual and family coverage plans; group medical, dental, pharmacy and vision coverage plans; Medicare supplement plans; preferred provider organization (PPO) plans; exclusive provider organization (EPO) plans; and traditional coverage plans to its customers ranging from individuals and families to members of Fortune 100 employer groups. The company is a not-for-profit independent licensee of the Blue Cross Blue Shield Association. PBC is headquartered at Mountlake Terrace in Washington, the US.

Premera Blue Cross Key Recent Developments

Dec 12,2018: Compass Health receives $75,000 Grant from Premera Blue Cross for Peer Recovery Center in Everett
Jul 10,2018: Premera and U.S. Anesthesia Partners Establish Value-Based Contract
Jul 03,2018: Premera & Providence Health Award Pioneer Human Services with Grants to Serve Homeless, Justice-Involved Individuals in Spokane
Jun 25,2018: Premera Awards Nearly $1 Million In Community Grants Focusing On Behavioral Health
Apr 18,2018: Premera Blue Cross Blue Shield of Alaska Receives Prestigious Brand Excellence Award

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
Section 1 – About the Company 5
Premera Blue Cross – Key Facts 5
Premera Blue Cross – Key Employees 6
Premera Blue Cross – Key Employee Biographies 7
Premera Blue Cross – Major Products and Services 8
Premera Blue Cross – History 9
Premera Blue Cross – Company Statement 12
Premera Blue Cross – Locations And Subsidiaries 13
Head Office 13
Other Locations & Subsidiaries 13
Joint Venture 13
Section 2 – Company Analysis 14
Company Overview 14
Premera Blue Cross – Business Description 15
Premera Blue Cross – SWOT Analysis 16
SWOT Analysis – Overview 16
Premera Blue Cross – Strengths 16
Premera Blue Cross – Weaknesses 17
Premera Blue Cross – Opportunities 18
Premera Blue Cross – Threats 19
Premera Blue Cross – Key Competitors 20
Premera Blue Cross, Recent Deals Summary 21
Section 3 – Company’s Recent Developments 22
Dec 12, 2018: Compass Health receives $75,000 Grant from Premera Blue Cross for Peer Recovery Center in Everett 22
Jul 10, 2018: Premera and U.S. Anesthesia Partners Establish Value-Based Contract 23
Jul 03, 2018: Premera & Providence Health Award Pioneer Human Services with Grants to Serve Homeless, Justice-Involved Individuals in Spokane 24
Jun 25, 2018: Premera Awards Nearly $1 Million In Community Grants Focusing On Behavioral Health 25
Apr 18, 2018: Premera Blue Cross Blue Shield of Alaska Receives Prestigious Brand Excellence Award 26
Section 4 – Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
Premera Blue Cross, Key Facts 5
Premera Blue Cross, Key Employees 6
Premera Blue Cross, Key Employee Biographies 7
Premera Blue Cross, Major Products and Services 8
Premera Blue Cross, History 9
Premera Blue Cross, Other Locations 13
Premera Blue Cross, Joint Venture 13
Premera Blue Cross, Key Competitors 20
Premera Blue Cross, Recent Deals Summary 21

★海外企業調査レポート[Premera Blue Cross:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ana Holdings Inc.:戦略・SWOT・企業財務分析
    Ana Holdings Inc. - Strategy, SWOT and Corporate Finance Report Summary Ana Holdings Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Knopp Biosciences LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Knopp Biosciences LLC (Knopp Biosciences) is a drug discovery and development company that offers medicines for the treatment of inflammatory and neurological diseases. The company’s pipeline products include dexpramipexole and KCNQ2. Its dexpramipexole is an anti-inflammatory therapeutic fo …
  • Vectura Group plc:企業の戦略・SWOT・財務分析
    Vectura Group plc - Strategy, SWOT and Corporate Finance Report Summary Vectura Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Zygo Corporation:企業の戦略的SWOT分析
    Zygo Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • 4P-Pharma SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary 4P-Pharma SAS (4P-Pharma) is a drug development company that offers drug pipeline for cancer and inflammatory diseases. The company’s pipeline product portfolio includes new chemical entities, biologics, added value generics and fixed dose combinations. Its pipeline candidates targets therap …
  • Ajinomoto Co., Inc.:企業の戦略・SWOT・財務分析
    Ajinomoto Co., Inc. - Strategy, SWOT and Corporate Finance Report Summary Ajinomoto Co., Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • PICC Property and Casualty Co Ltd:企業の戦略・SWOT・財務情報
    PICC Property and Casualty Co Ltd - Strategy, SWOT and Corporate Finance Report Summary PICC Property and Casualty Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • EP Petroecuador:企業の戦略的SWOT分析
    EP Petroecuador - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Flowserve Corp (FLS):企業の財務・戦略的SWOT分析
    Flowserve Corp (FLS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • LIXIL Group Corporation:企業の戦略・SWOT・財務情報
    LIXIL Group Corporation - Strategy, SWOT and Corporate Finance Report Summary LIXIL Group Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Mitsui & Co., Ltd.:企業のM&A・事業提携・投資動向
    Mitsui & Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Mitsui & Co., Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Alcami Corp:企業の戦略的SWOT分析
    Alcami Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Cobham plc:企業の戦略・SWOT・財務情報
    Cobham plc - Strategy, SWOT and Corporate Finance Report Summary Cobham plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • USG Corporation:企業の戦略・SWOT・財務情報
    USG Corporation - Strategy, SWOT and Corporate Finance Report Summary USG Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Ruby Tuesday, Inc.:企業の戦略・SWOT・財務情報
    Ruby Tuesday, Inc. - Strategy, SWOT and Corporate Finance Report Summary Ruby Tuesday, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Cabot Corp (CBT):企業の財務・戦略的SWOT分析
    Cabot Corp (CBT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Immunocore Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Immunocore Ltd (Immunocore) is a biotechnology company that focuses on the development of immunotherapeutic drugs for the treatment of cancer, infectious diseases and autoimmune diseases. The company develops its drugs using its proprietary T cell receptor (TCR) technology. Its products unde …
  • LGC Ltd-製薬・医療分野:企業M&A・提携分析
    Summary LGC Ltd (LGC) formerly LGC (Teddington) Limited, is a life sciences measurement and testing company which offers reference materials, genomics solutions and analytical testing products and services. Its products portfolio includes AutoGen, DNA extraction instrumentation, DNA extraction kits, …
  • Holland Colours NV (HOLCO):企業の財務・戦略的SWOT分析
    Holland Colours NV (HOLCO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Karolinska University Hospital:製薬・医療:M&Aディール及び事業提携情報
    Summary Karolinska University Hospital (KUH), a subsidiary of Karolinska Institutet is a healthcare service provider that offers patient care, research and education programs. The hospital offers cross border medical care by referring patients or by tele medicine and health care at a distance. It of …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆